WellMedr review: a good price, quoted in a month the billing does not use

It prices in months, and its own documents name four different periods

The two plan cards are clear enough on their face. Compounded tirzepatide: “Starting At $99 a month”, “Shipped every 4 weeks”, “Same price regardless of dosage”, “Cancel or change anytime”. Compounded semaglutide: “Starting At $59 a month”, shipped on the same cadence, cancel anytime, with nothing said either way about dose.

Then the site tells you three more things about when it charges you. The banner across every page sells “$59/mo on 12/month Plans”. The refund and cancellation policy opens with “Your subscription will automatically renew every 21 days”. And clause 6 of the Terms of Use says renewals run in “monthly, 3-month, or 6-month cycles depending on your plan”. Four documents, four periods, one price quoted per month.

We cannot tell you which one governs your card, so here is what each of them costs if you read it literally. These are WellMedr’s own published figures against WellMedr’s own published periods; we have added nothing.

The spread between the top row and the bottom row is 45%. We are not calling this a trick — a 21-day refill cycle can be an ordinary supply decision, and plenty of programs in this category ship on a 28-day cycle and describe it as monthly. It is simply not knowable from the site which one applies to you, and a difference of $317 a year on semaglutide or $533 on tirzepatide is worth one email before you enter a card.

One more thing about the $59. It is not a month-to-month rate: the site banner ties it to a twelve-month plan in as many words, and no standing month-to-month price is published anywhere on the site for either molecule. Both plan buttons open a checkout app that shows nothing until the medical intake is complete, so a buyer who wants to pay by the month cannot see what that costs before handing over a medical history. The $99 tirzepatide figure carries no such condition, and the difference matters: it is the one number here that is a real, unqualified, flat-dose rate.

Its FAQ says the medications are FDA approved. Its footer says they are not.

This is the single most consequential thing on the site, and it is one word long. The FAQ asks “Are these medications FDA approved?” and answers: “Yes. We only work with U.S. licensed pharmacies that dispense FDA-approved medications.” The microdose page says it a second time, in different words — “All GLP-1 medications used in Wellmedr programs are FDA-approved compounds”.

The footer of both of those pages says the opposite, and the footer is correct: “Compounded medications offered through Wellmedr. are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality.” So does the pricing page, which states the compounding caveat and the thyroid warnings plainly and in a place you cannot miss.

The distinction is not a technicality. FDA-registered describes a facility that has told the agency it exists. FDA-approved describes a drug that went through the approval process — trials, review, a decision. Compounded semaglutide and tirzepatide have done the first and not the second. Because the rest of WellMedr’s own site has this right, we read the “Yes” as one answer out of step rather than as the company’s position — but it is the answer sitting exactly where a reader with exactly that question will look for it, and it is the reason our score is where it is rather than higher.

The microdose line is where this gets closest to our shelf — and furthest from the evidence

WellMedr sells eight “microdose” products, four oral and four injectable, and they read like supplement stacks with a prescription drug folded in: tirzepatide with inositol, semaglutide with B12 and methionine, one blend of tirzepatide with NAD+, B12, magnesium and L-theanine sold for sleep. This is the closest thing in this category to the aisle we normally write about, and it is worth being clear about what it is: every one of them is a compounded prescription drug, not a supplement, and the combinations are formulation choices rather than tested products.

The page says so itself, in the small print: “Wellmedr. Microdosed GLP-1/GIP compounds have not been studied for specific health outcomes.” Two paragraphs further down, its FAQ says “Average weight loss is 10–17 pounds within 60 days”. Both sentences are on the same page. Only one of them can be the basis of a decision, and it is not the second.

The headline above all of it is “ZERO Side Effects”, and its own subhead one line below is “Zero side effct for 70%+ of members” — their spelling, and their arithmetic. Seventy percent of members is not zero, and the page carries no safety notice of its own; the thyroid C-cell and MTC warning we credited above lives on the pricing page, not here. GLP-1 medications have a real and well-documented side-effect profile, which is the whole reason microdosing is being sold in the first place.

On price, only two of the eight publish one — both $199/month — and the other six publish none. The product catalog behind all eight returns $0.00 for every item, which is a placeholder set before clinical review rather than a price, and we do not report it as one.

Its NAD+, B12 and sermorelin pages are one page with the name swapped

Alongside the GLP-1 business, WellMedr sells three compounded injectables on their own pages at $99 a month each: NAD+, vitamin B12 and sermorelin. Put the sermorelin page beside the B12 page and normalize the product name and they are word for word identical — the same 295 lines, the same headings, the same FAQ. The NAD+ page differs only in its title and one embedded video.

The substitution did not stop at the headings. Both of the other two pages print “(Nicotinamide Adenine Dinucleotide)” after the product name, and describe the product as “a naturally occurring coenzyme essential for mitochondrial function, DNA repair, and healthy aging”. Nicotinamide adenine dinucleotide is NAD+. Sermorelin is a 29-amino-acid analog of growth-hormone-releasing hormone; B12 is cobalamin; neither is that coenzyme. All three pages also offer “500mg and 1000mg injection options” — ordinary NAD+ figures, while sermorelin and B12 are both dosed in micrograms.

Nobody will be dispensed a gram of sermorelin; a prescriber sets the real dose after the intake, and that is exactly the point. The numbers on those pages are not describing the product being sold, and a reader has no way to tell which of the other statements on them are. It reads like one landing page duplicated twice with nobody reading the result — which is not fraud, but it is evidence about how closely the copy is being checked, on a site whose FAQ also says a compounded drug is FDA approved.

What WellMedr publishes that much of this category does not

Two questions matter more than any marketing claim in compounded telehealth: which pharmacy compounds and ships the drug, and who is signing the prescription. WellMedr answers both. Its privacy policy names “Mycelium Pharmacy — our U.S.-licensed fulfillment pharmacy” and sets out the arrangement in full: “Medical Provider Network: OpenLoop Health · Fulfillment Pharmacy Partner: Mycelium Pharmacy · Telehealth Platform: WellMedr”. Its telehealth consent names OpenLoop Healthcare Partners, PC and lists the affiliated state professional corporations individually.

That is a real disclosure and it earns real credit — it is also what let us screen the pharmacy against the FDA warning-letter index rather than only the brand, and both came back clean. The qualification is where the name lives: only in the privacy policy. It is not on the home page, the pricing page, the FAQ, the microdose page, the refund policy or any of the three longevity product pages. And no 503A or 503B claim appears anywhere on the site — what WellMedr publishes is “FDA-registered compounding facilities”, which is a registration fact rather than a compounding standard, and we do not credit one as the other here or on any other review.

What it does not publish is a list of the states it serves. Its FAQ answers that question with “We are expanding rapidly — eligibility is checked during sign-up”, so whether you can buy at all is something you find out by starting an intake.

WellMedr vs a ‘natural GLP-1’ supplement

A supplement and a prescription GLP-1 are not two strengths of the same thing. A berberine or a fiber works at the margins — nudging the gut’s role in appetite and blood-sugar signaling, with modest, realistic effects. A prescribed GLP-1 drug acts directly on the receptor at pharmacological strength; the effect size is in a different league, and so is the side-effect and cost profile. WellMedr’s microdose line is the interesting middle case, because it looks like our aisle — B12, inositol, methionine, magnesium, L-theanine — and is not: there is a prescription drug in every one of those blends, and the blends themselves are, by the page’s own admission, unstudied. Read our supplements vs GLP-1 drugs breakdown before you decide which lane you are in.